BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhao M, Yu Y, Wang R, Chang M, Ma S, Qu H, Zhang Y. Mechanisms and Efficacy of Chinese Herbal Medicines in Chronic Kidney Disease. Front Pharmacol 2020;11:619201. [PMID: 33854427 DOI: 10.3389/fphar.2020.619201] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Zheng H, Fu P, Chen H, Wang Z. Pseudorabies Virus: From Pathogenesis to Prevention Strategies. Viruses 2022;14:1638. [DOI: 10.3390/v14081638] [Reference Citation Analysis]
2 Tan W, Wang Y, Dai H, Deng J, Wu Z, Lin L, Yang J. Potential Therapeutic Strategies for Renal Fibrosis: Cordyceps and Related Products. Front Pharmacol 2022;13:932172. [DOI: 10.3389/fphar.2022.932172] [Reference Citation Analysis]
3 Blair HA. Hexanic Extract of Serenoa repens (Permixon®): A Review in Symptomatic Benign Prostatic Hyperplasia. Drugs Aging 2022;39:235-43. [PMID: 35237936 DOI: 10.1007/s40266-022-00924-3] [Reference Citation Analysis]
4 Xie D, Li K, Ma T, Jiang H, Wang F, Huang M, Sheng Z, Xie Y. Therapeutic Effect and Safety of Tripterygium Glycosides Combined With Western Medicine on Type 2 Diabetic Kidney Disease: A Meta-Analysis. Clinical Therapeutics 2022. [DOI: 10.1016/j.clinthera.2021.12.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Shao M, Ye C, Bayliss G, Zhuang S. New Insights Into the Effects of Individual Chinese Herbal Medicines on Chronic Kidney Disease. Front Pharmacol 2021;12:774414. [PMID: 34803715 DOI: 10.3389/fphar.2021.774414] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
6 Zakaria MM, Derbala SA, Salem AE, El-Agroudy AE, El-Tantawy FM. Inflammatory markers in chronic kidney disease and end stage renal disease patients. Mol Biol Rep 2021;48:6857-62. [PMID: 34472006 DOI: 10.1007/s11033-021-06684-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]